OPTIMIZERx Retains First Capital Investors for Investor Relations
21 Mai 2008 - 7:59PM
Marketwired
ROCHESTER, MI Corporation (PINKSHEETS: OPRX) announced today
that it has retained First Capital Investors, Inc. for investor
relations.
OPTIMIZERx's CEO, David Harrell, commented, "I believe that our
relationship with First Capital Investors will allow us to
effectively communicate our unique story to current and future
shareholders. Having recently become a public entity, we sought out
a relationship with a firm that has a solid understanding of how to
communicate with the investing public, an excellent reputation, and
who demonstrates professionalism on a daily basis. We believe that
we achieve all of this with First Capital."
All analysts, media, institutional and investor questions should
be directed to First Capital Investors at 321-221-2910. Additional
investor information, including an investor fact sheet, is
available for download at
http://www.firstcapitalinvestors.com/factsheets/oprx.pdf.
About OPTIMIZERx Corporation
OPTIMIZERx, www.optimizerx.com, is a web-based consumer health
care portal that provides savings, support and information to help
patients better afford and optimize their prescribed medicines and
therapies. The Company focuses on the design, implementation and
execution of rebates, discounts, educational and outreach programs;
positioning itself as the pivotal location between pharmaceutical
manufacturers, physicians and patients. As private health insurance
programs continue to push more drug costs down to the patient
level, OPTIMIZERx has positioned itself, both in terms of its
business strategy as well as its relationships with Big Pharma, to
capture a significant amount of the growth that is occurring in
this rapidly expanding industry.
About First Capital Investors, Inc.
First Capital Investors is a full-service Capital Markets
Advisory and Investor Relations firm. First Capital Investors
focuses primarily on small and micro cap companies seeking
professional representation to the investing public.
For additional information on OPTIMIZERx or to receive email
alerts, please visit: www.firstcapitalinvestors.com.
Forward-Looking Statements:
In this press release we make "forward-looking statements"
within the meaning of the U.S. Private Securities Litigation Reform
Act of 1995. Forward-looking statements describe future
expectations, plans, results or strategies and can often be
identified by the use of terminology such as "may," "will,"
"estimate," "intend," "continue," "believe," "expect,"
"anticipate," "could," "potential," "opportunity," or similar
terminology. These statements are based upon management's current
expectations, assumptions and estimates and are not guarantees of
future results or performance. Actual outcomes may differ
materially from those projected in these statements due to a
variety of risks and uncertainties and other factors, including,
among other things: competition; material adverse changes in
economic and industry conditions in our markets; technological
change; retention and renewal of existing contracts; availability
and adequacy of cash flow to satisfy obligations and indebtedness
or future needs; protection of intellectual property; security and
integrity of software and systems; laws and government regulation,
including those relating to gaming licenses, permits and
operations; seasonality; dependence on suppliers and manufacturers;
factors associated with foreign operations; dependence on key
personnel; failure to perform on contracts; resolution of pending
or future litigation; labor matters; and stock price volatility.
Additional information regarding risks and uncertainties and other
factors that could cause actual results to differ materially from
those contemplated in forward-looking statements is included from
time to time in our filings with the SEC, including our most recent
Annual Report on Form 10-K. Forward-looking statements speak only
as of the date they are made, and except for our ongoing
obligations under the U.S. federal securities laws, we undertake no
obligation to publicly update any forward-looking statements
whether as a result of new information, future events or
otherwise.
For further information, please contact: Investor Relations:
First Capital Investors, Inc. Email Contact (321) 221-2910
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024